ValuatePad Companies Glossary

Income statement Cash flow Margins Balance sheet Market Shareholder returns Debt management JP Valuation DCF valuation EPV & WACC valuation Quality scores News and calendar Consensus and analysts

Income statement Cash flow Margins Balance sheet

Fundamentals of 500+ US-listed companies, as reported to the SEC. Free, no signup.

Explore

All companies
Financial glossary
About

The data

Methodology
Sources

© 2026 ValuatePad. Informational and educational content only. Not investment advice.

Novo Nordisk A/S

NVO

Forward P/E: 14.21×
Mkt cap: 214 B USD
EV: 229 B USD
Sector: Healthcare
Coverage: 2022–2025
Currency: USD · DKK
Next event: Mar 16, 2027

DCF valuation

Assumptions

Valuation

FCF projection

Explained in the glossary

DCF (discounted cash flow)